Busy. Please wait.

show password
Forgot Password?

Don't have an account?  Sign up 

Username is available taken
show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
We do not share your email address with others. It is only used to allow you to reset your password. For details read our Privacy Policy and Terms of Service.

Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.

Remove ads
Don't know
remaining cards
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
restart all cards

Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how


Mabs, immunomodulators

Orthoclone OKT3 – Muromonab CD3 CD3, T cells prevent acute rejection of kidney, liver and heart transplants
Centoxin – Nebacumab lipid A polysaccharide portion of Gm- endotoxin Severe sepsis that has progressed to endotoxic shock
Abciximab Reopro GP IIb/IIIa receptor (member of integrin family) pts. w/ heart disease caused by poor blood flow in arteries of heart
Palivizumab Snygas RSV prevention of serious lower respiratory infection caused by RSV
Adalimumab Humira TNF alpha (blank)
Daclizumab Zenapax alpha subunit of IL-2 receptors (activated Tcells) kidney transplantation
Basiliximab Simulect alpha subunit of IL-2 receptor impairs immune response to antigen challenge
Infliximab Remicade TNF alpha rheumatoid arthritis and crohn’s disease
Efalizumab Raptiva LFA-1 to ICAM-1 treatment of psoriasis
Rituximab Rituxan CD20 antigen B cell lymphoma (CD20+), and non-Hodgkin’s lymphoma
Trastuzumab Herceptin (HER-2) treatment of breast cancer
Alemtuzumab Campath CD52 receptor B cell chronic lymphocytic leukemia
Gemtuzumab – ozogamacin Mylotarg CD33 receptor treatment of CD33 positive acute myeloid leukemia
Ibritumomab Zevalin CD20 B cell non-Hodgkin’s lymphoma
Tositumomab Bexxar CD20 receptors non-Hodgkin’s lymphoma
Panitumumab Vectibix epidermal growth factor receptors colorectal cancer pts
Centuximab Erbitux epidermal growth factor receptors (HER1 head, neck and colorectal cancers
Bevacizumab Avastin vascular endothelial growth factor (VEGF) malignant colon or rectal cancer
Cyclosporine (blank) targets calcineurin by binding with cyclophyllin all tissue transplantations
Tacrolimus (blank) binds to calcineurin via fk506 Tissue transplantation
Rapamycin Sirolimus FKPB (FK506) tissue transplantations, cancer—causes apoptosis
Everolimus (blank) - inhibits P7056 Prevention of graft rejection
Fingolimod (FTY 720) (blank) modulator of spingosine 1-phosphate receptor (blank)
Mycophenolate Mofetil (blank) (blank) (blank)
Created by: hansliza